Corrigendum to "Discovery of 1,3,4-oxadiazole derivatives as potential antitumor agents inhibiting the programmed cell death-1/programmed cell death-ligand 1 interaction" [Bioorg. Med. Chem. 46 (2021) 116370]

Affiliations

• ¹ Center for Drug Discovery, Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, China Pharmaceutical University, Nanjing 210009, PR China.
• ² College of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, PR China.
• ³ Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, PR China.
• ⁴ Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, PR China. Electronic address: jpzhou668@163.com.
• ⁵ Center for Drug Discovery, Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, China Pharmaceutical University, Nanjing 210009, PR China. Electronic address: zhanghb80@163.com.